Stockscreener 앱 받기
75.56
0.64%
0.48
시간 외 거래:
76.00
0.44
+0.58%
전일 마감가:
$75.08
열려 있는:
$75.86
하루 거래량:
5.16M
Relative Volume:
0.76
시가총액:
$31.68B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
12.52
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
+1.02%
1개월 성능:
-7.05%
6개월 성능:
-40.58%
1년 성능:
-52.42%
1일 변동 폭
$75.25
$76.99
1주일 범위
$73.06
$77.99
52주 변동 폭
$71.47
$160.48
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
75.56 | 31.48B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
16.56 | 53.04B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.76 | 42.76B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.95 | 38.54B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
547.06 | 23.45B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Zoetis stock reflects resilient animal health demand despite thin recent news flow - ad-hoc-news.de
New EU Poultry Vaccine Approval Might Change The Case For Investing In Zoetis (ZTS) - simplywall.st
ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS - GlobeNewswire Inc.
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors - GlobeNewswire
Zoetis stock reflects steady animal health demand as investors track long term growth - ad-hoc-news.de
An opportunity to honor special equine vets - Equus Magazine
ZTS Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
Zoetis aims to combine best of both worlds following VPG acquisition - Vet Times
Y Intercept Hong Kong Ltd Invests $1.87 Million in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Acquired by Munich Reinsurance Co Stock Corp in Munich - MarketBeat
Peterson Wealth Services Has $1.90 Million Holdings in Zoetis Inc. $ZTS - MarketBeat
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
ZTS Stockholders Have Opportunity to Lead Zoetis Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
ZOETIS INC. (ZTS) SHAREHOLDER ALERT Bernstein Liebhard LLP - GlobeNewswire
Resona Asset Management Co. Ltd. Acquires 20,771 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Wins EU Vaccine Approval With Undervalued View Still In Focus - simplywall.st
Isthmus Partners LLC Has $12.01 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zoetis Inc focuses on long-term growth drivers in animal health - Ad-hoc-news.de
Zoetis Receives European Commission Marketing Authorization for Poulvac Procerta HVT ND - Pet Age
Zhitnitskiy recognized with the Zoetis Distinguished Teaching Award - National Hog Farmer
Zoetis (ZTS) Gains EU Approval for New Poulvac Vaccine - GuruFocus
ZTS DEADLINE: Levi & Korsinsky Reminds Zoetis Inc. Investors of Upcoming Securities Class Action Deadline - AOL.com
Zoetis Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsZTS - AOL.com
Zoetis Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm - AOL.com
Zoetis Deadline: ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit - AOL.com
Zoetis Inc. (ZTS) Class Action Lawsuit: Investors July 27 2026, DeadlineContact KTMC - AOL.com
Zoetis receives EU authorization for Newcastle vaccine in poultry - Feedstuffs
Zoetis Inc. $ZTS Shares Bought by Swedbank AB - MarketBeat
Zoetis receives EU approval for Poulvac Procerta HVT-ND vaccine - grafa.com
Portnoy Law Firm Announces Class Action on Behalf of Zoetis, Inc. Investors - GlobeNewswire
Stephens Inc. AR Lowers Stake in Zoetis Inc. $ZTS - MarketBeat
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
'Risk-reward is really starting to pique my interest': Cobb on Zoetis - BNN Bloomberg
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND - Business Wire
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ZTS Maintained by HSBC -- Price Target Lowered to $95 - GuruFocus
Zoetis Inc. Faces Securities Fraud Lawsuit Over Misleading Inves - GuruFocus
Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost - GlobeNewswire
HSBC Adjusts Price Target on Zoetis to $95 From $140 - marketscreener.com
Zoetis Inc. (ZTS) Stock Analysis: Exploring A Potential 58% Upside - DirectorsTalk Interviews
ZTS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Zoetis: The 60% Decline Was Justified, But Shares Are Finally Buyable - Seeking Alpha
Zoetis Plunges on Earnings Miss and Lowered Guidance - marketscreener.com
Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - NewMediaWire
Why is Zoetis stock collapsing today? - Investing.com
ZTS INVESTOR DEADLINE: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - TMX Newsfile
Steigerwald Gordon & Koch Inc. Trims Stake in Zoetis Inc. $ZTS - MarketBeat
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
조에티스 주식 (ZTS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bisaro Paul | Director |
May 13 '26 |
Buy |
75.88 |
2,000 |
151,750 |
27,862 |
| MCCALLISTER MICHAEL B | Director |
May 11 '26 |
Buy |
77.76 |
3,000 |
233,273 |
24,524 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Option Exercise |
41.83 |
20,000 |
836,600 |
121,337 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Sale |
127.05 |
20,000 |
2,540,964 |
101,337 |
0.45%
0.51%
자본화:
|
볼륨(24시간):